Nanalysis Scientific Corp (NSCI.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 11,474 | 11,162 | 9,800 | 7,036 | 6,956 |
| Cost of Goods | 8,259 | 8,809 | 8,081 | 5,410 | 5,672 |
| Gross Profit | 3,215 | 2,353 | 1,719 | 1,626 | 1,284 |
| Operating Expenses | 4,274 | 4,059 | 3,656 | 4,334 | 5,119 |
| Operating Income | -1,059 | -1,706 | -1,937 | -2,708 | -3,835 |
| Interest Expense | N/A | 354 | N/A | 289 | N/A |
| Other Income | -942 | -454 | 796 | -3,411 | -531 |
| Pre-tax Income | -2,001 | -2,514 | -1,141 | -6,408 | -4,366 |
| Income Tax | -6 | 8 | 982 | -121 | -312 |
| Net Income Continuous | -1,995 | -2,522 | -2,123 | -6,287 | -4,054 |
| Minority Interests | 0 | 0 | N/A | 0 | 223 |
| Net Income | $-1,995 | $-2,522 | $-2,711 | $-6,287 | $-3,831 |
| EPS Basic Total Ops | -0.02 | -0.02 | -0.02 | -0.06 | -0.04 |
| EPS Basic Continuous Ops | -0.02 | -0.02 | -0.02 | -0.06 | -0.04 |
| EPS Diluted Total Ops | -0.02 | -0.02 | -0.02 | -0.06 | -0.04 |
| EPS Diluted Continuous Ops | -0.02 | -0.02 | -0.02 | -0.06 | -0.04 |
| EBITDA(a) | $95 | $-1,008 | $2,990 | $-4,986 | $-2,619 |